Plain-English translation of NCT06960382 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Allergic Rhinitis research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new way to treat cat allergies using ALUTARD SQ Felis domesticus — a cat allergen extract — but delivered differently than standard allergy shots. Instead of the traditional approach that requires about 50 injections over 3 years, this medication is injected directly into a lymph node in your groin, with only 3 injections total. Researchers believe this new method might be safer and more effective because it uses much smaller doses and avoids areas of the body that could trigger severe allergic reactions.
Many people with cat allergies aren't offered traditional allergy treatment because it carries risks like asthma flare-ups or severe allergic reactions. This new approach aims to provide a safer alternative that might help more patients benefit from allergy immunotherapy.
You likely qualify if…
You likely don't qualify if…
You will receive three injections of the medication directly into a lymph node in your groin over several weeks. Before, during, and after treatment, you'll have blood tests, breathing tests, and fill out questionnaires about your symptoms and quality of life. The study team will carefully monitor you for any allergic reactions and track how your body responds to the treatment. The entire study lasts several months, with follow-up visits to measure how well the treatment works and ensure it remains safe.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Switzerland